Table 3.
Blood pressure
| REGARDS reference—author | Year | Topic |
|---|---|---|
| [15]—Glasser et al. | 2011 | Prevalence of prehypertension and risk factors. |
| [16]—Judd et al. | 2011 | Alcohol consumption and hypertension |
| [17]—Glasser et al. | 2013 | Prehypertension and CHD incidence |
| [23]—Banach et al. | 2014 | Medication adherence and cardiovascular mortality |
| [26]—Cummings et al. | 2013 | Medication nonadherence and BP control |
| [27•]—Cummings et al. | 2013 | Access to generic medications and BP control |
| [29]—Cummings et al. | 2010 | Racial disparities in BP control |
| [30]—Safford et al. | 2007 | Treatment disparities between AAs and whites |
| [33]—Durrant et al. | 2010 | BP control and trust in physicians |
| [35]—Durrant et al. | 2012 | Awareness and treatment of hypertension in health professional shortage areas |
| [36]—Howard et al. | 2006 | Racial disparities in awareness and treatment of hypertension |
| [39]—Kent et al. | 2011 | Environmental influence on BP control |
| [42]—Levine et al. | 2011 | Waist circumference and BP control |
| [46]—Muntner et al. | 2010 | Antihypertensive medication adherence in chronic kidney disease |
| [48]—Irvin et al. | 2014 | aTRH and CHD risk |
| [49]—Irvin et al. | 2012 | Medication nonadherence and pseudoresistant hypertension |
| [53]—Tanner et al. | 2014 | aTRH and end stage renal disease |
| [55]—Calhoun et al. | 2014 | Refractory hypertension and lack of optimal medication regimen |
| [58]—Diaz et al. | 2014 | Healthy life style factors and cardiovascular events |
| [59]—Shimbo et al. | 2013 | Unhealthy life style risk factors and number of antihypertensive medications |
| [65]—Glasser et al. | 2014 | Pulse pressure and CHD risk |